Therapy Areas: Cardiovascular
Boehringer Ingelheim's VETMEDIN gains US FDA approval to delay congestive heart failure onset in dogs
20 January 2026 - German biopharmaceutical company Boehringer Ingelheim announced on Monday that the US Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) Chewable Tablets and VETME...
Myqorzo and Redemplo receive regulatory approval in China
15 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that China's National Medical Products Administration has approved two Sanofi-licen...
Cereno Scientific publishes first peer-reviewed data on CS014, highlighting antithrombotic efficacy without bleeding risk
14 January 2026 - Biotechnology company Cereno Scientific (Nasdaq First North: CRNO B) on Wednesday reported publication of the first peer-reviewed manuscript on its HDAC inhibitor CS014 in the Journa...
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
13 January 2026 - Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a US-based wearable medical device and digital healthcare company, announced on Tuesday that it has entered a strategic collaboratio...
Organon signs commercialisation agreement for Nilemdo across six European markets
8 January 2026 - US healthcare company Organon (NYSE:OGN) announced on Thursday that it has entered into a commercialisation agreement with Daiichi Sankyo Europe to distribute and promote Nilemdo in F...
Antin to acquire clinical trial equipment provider Emsere
8 January 2026 - Private equity firm Antin Infrastructure Partners (Euronext Paris:ANTIN) announced on Thursday that it has agreed to acquire Emsere from Dutch family investment platform Gryphion.Emse...